News

First-in-Class Medicines against Uveal Melanoma and its Neovascular complications

Fundraising

Roca Therapeutics announcing new financing from Provence-Alpes-Côte d’Azur and Massif des Alpes FEDER-FSE+-FTJ 2021-2027 program

05/06/25

Read more

Join Us

Connect With Us

Explore partnership opportunities and learn more about our mission to revolutionize medicines for ocular disease

Contact Us